Järfälla, Sweden

Helena Persson

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Alligator Bioscience Ab. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Helena Persson. Retrieved from https://idiyas.com/inventor/helena-persson-yrfojcre

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Helena Persson - Innovator in Antibody Technology

Introduction

Helena Persson is a notable inventor based in Jarfalla, Sweden. She has made significant contributions to the field of biotechnology, particularly in the development of antibody libraries. Her work has the potential to advance therapeutic applications and improve disease treatment.

Latest Patents

Helena holds 1 patent for her invention of a scFV antibody library. This invention provides libraries of antibody molecules and nucleic acids encoding these molecules. It also includes methods for producing these libraries and selecting antibodies that specifically bind to antigens. The libraries consist of various antibody variable domains generated by creating diversity in the CDR regions.

Career Highlights

Helena is currently employed at Alligator Bioscience AB, a company focused on developing innovative immunotherapies. Her role involves research and development in antibody technology, contributing to the advancement of therapeutic solutions.

Collaborations

Helena collaborates with Peter Ellmark, a fellow researcher at Alligator Bioscience AB. Together, they work on projects that aim to enhance the efficacy of antibody-based therapies.

Conclusion

Helena Persson's innovative work in antibody technology exemplifies the impact of research and development in biotechnology. Her contributions are paving the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…